We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+1.95%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$82.5B
AUM Growth
-$470M
(-0.57%)
Cap. Flow
-$219M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
13.85%
Holding
751
New
67
Increased
353
Reduced
251
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$531M |
| 2 |
Microchip Technology
MCHP
|
+$311M |
| 3 |
Check Point Software Technologies
CHKP
|
+$243M |
| 4 |
Sanofi
SNY
|
+$224M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$364M |
| 2 |
Vertiv
VRT
|
+$292M |
| 3 |
FITB
Fifth Third Bancorp
FITB
|
+$274M |
| 4 |
HF Sinclair
DINO
|
+$253M |
| 5 |
TGNA
TEGNA Inc
TGNA
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.6% |
| 2 | Healthcare | 16.65% |
| 3 | Technology | 14.96% |
| 4 | Industrials | 14.22% |
| 5 | Energy | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
ITT
ITT
$17.3B
| $94.6M | 0.11% |
1,258,317
-1,089,589
| -46% | -$96.2M |
|
202
Avery Dennison
AVY
$12.4B
| $93.2M | 0.11% |
535,459
+13,412
| +3% | +$2.49M |
|
|
MRO
203
DELISTED
Marathon Oil Corporation
MRO
| $92.9M | 0.11% |
3,698,758
-1,577,935
| -30% | -$33.9M |
|
204
Landstar System
LSTR
$6.55B
| $92.3M | 0.11% |
612,737
+259,933
| +74% | +$41.3M |
|
205
Insight Enterprises
NSIT
$3.67B
| $91.4M | 0.11% |
859,389
+8,409
| +1% | +$854K |
|
206
Stride
LRN
$3.88B
| $89.4M | 0.11% |
2,470,875
+3,551
| +0.1% | +$118K |
|
207
Belden
BDC
$4.04B
| $80.4M | 0.1% |
1,464,765
-11,718
| -0.8% | -$675K |
|
208
Allstate
ALL
$67.3B
| $79.7M | 0.1% |
575,119
-8,756
| -1% | -$1.1M |
|
209
Arrow Electronics
ARW
$10.6B
| $79.5M | 0.1% |
670,334
-58,398
| -8% | -$7.32M |
|
210
Kosmos Energy
KOS
$1.48B
| $78.8M | 0.1% |
10,859,683
-484,884
| -4% | -$2.47M |
|
211
Allison Transmission
ALSN
$9.97B
| $77.1M | 0.09% |
1,971,656
+13,881
| +0.7% | +$546K |
|
212
ABM Industries
ABM
$2.85B
| $74.7M | 0.09% |
1,612,248
+12,258
| +0.8% | +$533K |
|
213
Assured Guaranty
AGO
$3.8B
| $73.6M | 0.09% |
1,168,392
-305,581
| -21% | -$17.5M |
|
214
Dollar General
DG
$27.2B
| $73M | 0.09% |
327,586
+1,563
| +0.5% | +$332K |
|
215
Shell
SHEL
$242B
| $71M | 0.09% |
+1,292,177
| New | +$68.6M |
|
|
IPG
216
DELISTED
Interpublic Group of Companies
IPG
| $69.4M | 0.08% |
1,956,982
-63,749
| -3% | -$2.3M |
|
217
EnerSys
ENS
$6.76B
| $68.6M | 0.08% |
922,447
-8,967
| -1% | -$670K |
|
|
SYNH
218
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $62.8M | 0.08% |
770,435
+1,281
| +0.2% | +$108K |
|
|
AUY
219
DELISTED
Yamana Gold, Inc.
AUY
| $62.7M | 0.08% |
+9,121,073
| New | +$43.1M |
|
220
AXIS Capital
AXS
$8.66B
| $61.7M | 0.07% |
1,028,011
-17,418
| -2% | -$970K |
|
221
Markel Group
MKL
$25.2B
| $61.7M | 0.07% |
41,831
-1,237
| -3% | -$1.6M |
|
222
Walker & Dunlop
WD
$1.67B
| $60.6M | 0.07% |
469,548
-2,078
| -0.4% | -$285K |
|
223
Evercore
EVR
$13B
| $59.5M | 0.07% |
539,077
-21,412
| -4% | -$2.63M |
|
224
US Bancorp
USB
$99.1B
| $58.8M | 0.07% |
1,106,473
-17,301
| -2% | -$994K |
|
225
PACCAR
PCAR
$69.4B
| $58.6M | 0.07% |
998,246
-32,154
| -3% | -$1.96M |
|
Similar funds
Boston Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Boston Partners held 751 positions worth $82.5B, down 0.57% from $83B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Boston Partners's Q1 2022 filing shows 67 new, 353 increased, 251 reduced and 53 closed positions. Its largest new stake was Microchip Technology: 4,127,908 shares worth $310M. The largest sale was Citigroup, an estimated $364M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q1 2022 buy was Microchip Technology: 4,127,908 shares worth $310M.
- Boston Partners added most to Procter & Gamble in Q1 2022, an estimated $531M increase.
- Boston Partners's biggest Q1 2022 reduction was Citigroup, cutting an estimated $364M.
- Boston Partners fully exited Vertiv in Q1 2022, selling an estimated $292M.
- Boston Partners's ten largest holdings make up 14% of its $82.5B portfolio in Q1 2022.
- Boston Partners opened 67 new positions and closed 53 in Q1 2022.
- Boston Partners's portfolio value fell 0.57% quarter-over-quarter to $82.5B.
Based on Boston Partners's 13F filing for Q1 2022, filed 10 May 2022.